Robin Vos
Pneumologist and Associate Professor at KU Leuven and UZ Leuven whose research addresses post-transplant lung rejection, CLAD and pulmonary chronic graft-versus-host disease.
As of . Primary source: ORCID record 0000-0002-3468-9251.
Summary
According to his ORCID biography, Robin Vos is Associate Professor and Deputy Head of Clinic of the Department of Respiratory Diseases at KU Leuven and University Hospitals Leuven, with clinical and translational research on the pathophysiology and treatment of post-transplant lung graft rejection and pulmonary chronic graft-versus-host disease. The KU Leuven research portal lists him as promotor of a project on translational research on chronic rejection after lung transplantation, within the Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), covering clinical intervention studies, biobank analyses, in vitro work and a murine model.
Ranking method and caveats
Methodology for the researcher ranking
- Query: OpenAlex works of type article or review whose title or abstract contains "chronic lung allograft dysfunction" or "restrictive allograft syndrome", or "bronchiolitis obliterans" together with lung transplant terms. Retracted works and meeting-abstract supplements are removed.
- Window and date: works published 2016-10-11 to 2026-10-10; counts retrieved 2026-10-10 (2,461 works, 8,698 author profiles after merging).
- Counting: the rank is by total citations of the author's papers (whole counting). Fractional counts, first or last author papers and counts without the two 2019 ISHLT consensus papers are shown on each record.
- Identity: authors are identified by OpenAlex author identifier and ORCID. Duplicate profiles were merged by identical ORCID, or by compatible name plus shared institution. Only the top 30 entries were checked by hand.
- Rising researchers: a separate numbered list ordered by citations in the 5 years from 2021-10-11, for authors whose first paper in the corpus is dated 2019 or later and who have at least 5 papers in that window. It is a proxy, not a measure of career stage.
- Caveats: the corpus includes papers only partly about CLAD; consensus papers inflate some totals; recent papers are under-cited; author identifiers can be wrong; citations measure attention, not quality or clinical skill.
Details
- role
- Associate Professor and Deputy Head of Clinic, Respiratory Diseases (KU Leuven; UZ Leuven)
- affiliation
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven; University Hospitals Leuven
- citation rank 10y
- 1 of 8,698 author profiles (top 100 listed)
- papers 10y
- 139
- fractional papers 10y
- 16.25
- citations 10y
- 3408
- fractional citations 10y
- 355.8
- lead author papers 10y
- 51
- citations excluding two ishlt2019consensus papers
- 2155
- rank excluding two ishlt2019consensus papers
- 1
- ranking retrieved
- 2026-10-10
- orcid
- 0000-0002-3468-9251
- openalex author id
- A5033618310
- merged open alex profiles
- 4
- affiliation basis
- ORCID record, employment entries without an end date (self-asserted, may be out of date)
Sources and links
- ORCID record 0000-0002-3468-9251 (primary)
- UZ Leuven physician page
- KU Leuven research portal project
- OpenAlex author profile (ranking source)
- Most-cited CLAD paper in corpus: Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT (The Journal of Heart and Lung Transplantation, 2019); 952 citations; DOI 10.1016/j.healun.2019.03.009
- Most-cited CLAD paper in corpus: Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome―A consensus report from the Pulmonary Council of the ISHLT (The Journal of Heart and Lung Transplantation, 2019); 301 citations; DOI 10.1016/j.healun.2019.03.008
- Most-cited CLAD paper in corpus: Chronic lung allograft dysfunction phenotypes and treatment (Journal of Thoracic Disease, 2017); 125 citations; DOI 10.21037/jtd.2017.07.81
- Most-cited CLAD paper in corpus: Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial (PLOS ONE, 2018); 59 citations; DOI 10.1371/journal.pone.0193564
- Most-cited CLAD paper in corpus: The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis (Modern Pathology, 2018); 56 citations; DOI 10.1038/modpathol.2017.180
Related
Links from this record
- member of: KU Leuven BREATHE (Laboratory of Respiratory Diseases and Thoracic Surgery)
- author: Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction
- author: Donor-derived cell-free DNA in chronic lung allograft dysfunction phenotypes: a pilot study
- author: Clinical predictors for restrictive allograft syndrome: A nested case-control study.
- author: A transcriptomic atlas of chronic lung allograft dysfunction.
- author: Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction
- author: European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction
- author: International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition
- author: Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres
- author: Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement
- author: Ventilatory capacity in CLAD is driven by dysfunctional airway structure
- author: A European multicentre, randomised controlled trial of pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation
- author: Early Economic Model of Extracorporeal Photopheresis and Other Treatments of Chronic Lung Allograft Dysfunction After Lung Transplantation
- author: Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
- author: Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
- author: Global approaches to chronic lung allograft dysfunction: Toward evidence-based harmonization
- author: Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment: A consensus report from the Pulmonary Council of the ISHLT
- author: Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome: A consensus report from the Pulmonary Council of the ISHLT
- author: Chronic lung allograft dysfunction phenotypes and treatment
Linked from (derived)
- coauthor: Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction
- coauthor: Donor-derived cell-free DNA in chronic lung allograft dysfunction phenotypes: a pilot study
- coauthor: Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction
- coauthor: European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction
- coauthor: International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition
- coauthor: Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres
- coauthor: Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement
- coauthor: Ventilatory capacity in CLAD is driven by dysfunctional airway structure
- coauthor: A European multicentre, randomised controlled trial of pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation
- coauthor: Early Economic Model of Extracorporeal Photopheresis and Other Treatments of Chronic Lung Allograft Dysfunction After Lung Transplantation
- coauthor: Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
- coauthor: Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
- coauthor: Global approaches to chronic lung allograft dysfunction: Toward evidence-based harmonization
Known gaps in this record
- current funding grant numbers (the ORCID text states support from national and international funds without detail)
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.